15249618

Source:http://linkedlifedata.com/resource/pubmed/id/15249618

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001811, umls-concept:C0035647, umls-concept:C0043210, umls-concept:C0232970, umls-concept:C0279025, umls-concept:C0338656
pubmed:issue	1
pubmed:dateCreated	2004-7-13
pubmed:abstractText	A randomized trial of postmenopausal women over age 65 reported increased risks of cognitive decline with 4 years of combined estrogen and progestin treatment. However, questions remain, including the effect of longer duration or of hormone therapy initiated at younger ages.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/AG13483, http://linkedlifedata.com/resource/pubmed/grant/AG15424, http://linkedlifedata.com/resource/pubmed/grant/CA87969
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E, http://linkedlifedata.com/resource/pubmed/chemical/Progestins
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1526-632X
pubmed:author	pubmed-author:GrodsteinFrancineF, pubmed-author:KangJae HJH, pubmed-author:WeuveJenniferJ
pubmed:issnType	Electronic
pubmed:day	13
pubmed:volume	63
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	101-7
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15249618-Age Factors, pubmed-meshheading:15249618-Aged, pubmed-meshheading:15249618-Aged, 80 and over, pubmed-meshheading:15249618-Aging, pubmed-meshheading:15249618-Alzheimer Disease, pubmed-meshheading:15249618-Apolipoproteins E, pubmed-meshheading:15249618-Boston, pubmed-meshheading:15249618-Cognition Disorders, pubmed-meshheading:15249618-Cohort Studies, pubmed-meshheading:15249618-Disease Progression, pubmed-meshheading:15249618-Estrogen Replacement Therapy, pubmed-meshheading:15249618-Female, pubmed-meshheading:15249618-Genetic Predisposition to Disease, pubmed-meshheading:15249618-Genotype, pubmed-meshheading:15249618-Hormone Replacement Therapy, pubmed-meshheading:15249618-Humans, pubmed-meshheading:15249618-Neuropsychological Tests, pubmed-meshheading:15249618-Nurses, pubmed-meshheading:15249618-Postmenopause, pubmed-meshheading:15249618-Progestins, pubmed-meshheading:15249618-Prospective Studies, pubmed-meshheading:15249618-Questionnaires, pubmed-meshheading:15249618-Risk, pubmed-meshheading:15249618-Socioeconomic Factors
pubmed:year	2004
pubmed:articleTitle	Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.
pubmed:affiliation	Channing Lab, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. nhjhk@channing.harvard.edu
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't